CERS - Pendapatan operasional sadurunge ngurangi amortisasi Cerus

Logo perusahaan publik Cerus (CERS)

Effective management at Cerus Corporation (CERS) ensures revenue transparency for the Intercept system and high regulatory proficiency. Absolute EBITDA on this chart demonstrates the business's resilience to market shocks, while 0.00 expresses the current value of the metric. The humanitarian status of the products offsets geopolitical risks, and the top management's persistence in the global implementation of technologies solidifies the company's leadership in transfusion medicine.

Cerus Corporation (CERS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi saka 23.11.2025 nganti 14.11.2026

Ringkesan rincian data analitis Cerus (CERS)

Pambiji fundamental perusahaan:CERS (Cerus Inc)
Sampel barang Cerus Corp.

Cerus Corporation (CERS) maintains a monopoly position secured by patents for the INTERCEPT system and stringent FDA oversight, which creates a sustainable cash flow. Quarterly EBITDA figures quantify this model by excluding non-cash revaluations and demonstrating the business's actual ability to generate operating cash, allowing investors to assess the real efficiency of the business regardless of accounting adjustments.

Pesaing Cerus Corporation (CERS)

Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi ISRG|Danaher Corp. - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi bd.com BDX|STERIS (STE) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi WST|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Baxter Corp|Masimo Inc. (MASI) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi STVN (Stevanato Group S.p.A.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TFX|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Merit Medical MMSI|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi NVST|ICUI: Bathi operasional sadurunge ngurangi amortisasi|XRAY - Bathi operasional EBITDA|LeMaitre Vascular, Inc. (LMAT) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi atricure.com|STAA (STAAR Surgical) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi ChromaDex Corp NAGE|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ZimVie Dental (ZIMV)|AngioDynamics Inc. - Bathi operasional sadurunge amortisasi|Alpha Teknova, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MGRM (monogramorthopedics.com)|STSS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi InfuSystem Holdings INFU|UTMD: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi KORU Medical|NYXH (Nyxoah S.A.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi microbotmedical.com MBOT|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pro-Dex (PDEX)|ZTEK (Zentek Ltd) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Elutia Corp - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Milestone Scientific Corporation MLSS|NXGL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Retractable Technologies RVP|HBIO (Harvard Bioscience) - Bathi operasional sadurunge ngurangi amortisasi|Femasys Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|MHUA (Meihua Medical Technologies) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Predictive Oncology Corp (POAI)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Callan JMB Inc (CJMB)|ATRI - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi NeuroMetrix NURO